AM3 administration appears to reverse the non-responder status to hepatitis B vaccination in haemodialysis (HD) patients.

被引：0
|
作者：
Jarillo, MD
GarciaMartin, F
Sada, G
Calvo, CG
Prieto, A
Goni, M
Villarubia, VG
deMon, MA
机构：
[1] UNIV ALCALA DE HENARES, IMMUNOL IF CANTABRIA, HOSP GEN GUADALAJARA, SERV NEPHROL, MADRID, SPAIN
[2] UNIV ALCALA DE HENARES, IMMUNOL IF CANTABRIA, HOSP GEN GUADALAJARA, INTERNAL MED SERV, MADRID, SPAIN
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A2640 / A2640
页数：1
相关论文
共 42 条
  • [1] AM3 (Inmunoferon®) as an adjuvant to hepatitis B vaccination in hemodialysis patients
    Pérez-García, R
    Pérez-García, A
    Verbeelen, D
    Bernstein, ED
    Villarrubia, VG
    Alvarez-Mon, M
    KIDNEY INTERNATIONAL, 2002, 61 (05) : 1845 - 1852
  • [2] INTERFERON AS AN ADJUVANT FOR HEPATITIS-B VACCINATION IN NON-RESPONDER AND LOW-RESPONDER POPULATIONS
    GROB, PJ
    JOLLERJEMELKA, HI
    BINSWANGER, U
    ZARUBA, K
    DESCOEUDRES, C
    FERNEX, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (03) : 195 - 198
  • [3] Management of non-responder health care workers to hepatitis B routine vaccination
    Varshochi, Mojtaba
    Shahi, Jafar Mohammad
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (04): : 4551 - 4554
  • [4] Hepatitis C viral dynamics with triple vs double therapy in non-responder patients.
    Jaeckel, E
    Koerbel, J
    Kunka, A
    Schueler, A
    Heringlake, S
    Wedemeyer, H
    Trautwein, C
    Magerstedt, P
    Zankel, M
    Brinkmann, S
    HEPATOLOGY, 1999, 30 (04) : 264A - 264A
  • [5] Intradermal Hepatitis B Vaccination in Non-responder People Living with Human Immunodeficiency Virus in Japan
    Yoshimura, Yukihiro
    Sasaki, Hiroaki
    Miyata, Nobuyuki
    Tachikawa, Natsuo
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (05) : 519 - 522
  • [6] The adjuvant activity of AM3 (Inmunoferon®) to hepatitis B (HBV) vaccination in haemodialysis patients is due to its ability to restore the innate as well as the adaptative immunity
    Reyes, E
    Prieto, A
    Monserrat, J
    Gonzalez, S
    Villarrubia, VG
    Alvarez-Mon, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 123 - 124
  • [7] The adjuvant activity of AM3 (Inmunoferon®) to hepatitis B vaccination in haemodialysis patients is due to its ability to restore the innate as well as the specific immune responses.
    Reyes, E
    Prieto, A
    Monserrat, J
    Villarrubia, V
    Alvarez-Mon, M
    HEPATOLOGY, 2002, 36 (04) : 371A - 371A
  • [8] Activation of B-CLL cells by anti CD180 monoclonal antibodies: Responder and non-responder patients.
    Porakishvili, N
    Slovick, A
    Jewell, AP
    Youinou, PY
    Nathwani, A
    Yong, K
    Stevenson, F
    Clark, EA
    Lydyard, PM
    BLOOD, 2003, 102 (11) : 432A - 432A
  • [9] LOW-DOSE INTERLEUKIN-2 THERAPY NORMALIZES THE NON-RESPONDER STATE OF DIALYSIS PATIENTS TO HEPATITIS-B VACCINATION
    KOHLER, H
    DUMANN, H
    ZUMBUSCHENFELDE, KHM
    MEUER, SC
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 370 - 370
  • [10] Investigation of the frequencies of various B cell populations in non-responder healthcare workers in comparison with responders to hepatitis B virus vaccination
    Karimi, Sara
    Mehdipour, Fereshteh
    Sarvari, Jamal
    Ataollahi, Mohammad Reza
    Ramezani, Amin
    Meri, Seppo
    Kalantar, Kurosh
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2023, 117 (09) : 628 - 636
12345